lenvatinib 4mg

lenvatinib 4mg is a type of targeted therapy which aim the specific cancer cells therefore reduces side effects caused by affected cells. lenvatinib 4mg is a multi-kinase inhibitor and antineoplastic agents lenvatinib 4mg interfering with a protein which promotes cell division by preventing the cancer cell growth.



Eisai Co. Ltd

INDICATION OF lenvatinib 4MG

lenvatinib 4mg is used in adult for the treatment of metastatic, progressive, radioactive Differentiated Thyroid cancer.

lenvatinib 4mg in combination with everolimus is used in patients for the treatment of advance Renal Cell Carcinoma following treatment before anti-angiogenic therapy

lenvatinib 4mg is also indicated for the first line treatment in patients suffering with unresectable hepatocellular carcinoma.


Lenvatinib is a inhibitor of RTK (receptor tyrosine kinase) that interfere with the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4).

Lenvatinib also blocks other RTKs which have been suspected in pathogenic angiogenesis,growth of tumor, and cancer breakthrough in addition to their normal cellular activity, involves the fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet imitative growth factor receptor alpha (PDGFRα), KIT, and RET.


Duration of peak plasma concentration is 1 to 4 hours post dose. Effect with food is low to the extent Lenvatinibof absorption.

Lenvatinib binding to human plasma proteins is 98% to 99%.

lenvatinib 4mg is mainly metabolized in CYP3A. lenvatinib 4mg metabolic pathway is identified as enzymatic and non-enzymatic processes.

Excreted via 64% feces and 25% urine


Ingredients Lenvatinib
Strength 4mg
Manufactured Eisai Co. Ltd


The prescribed dose of Lenvatinib for the adult patients is 24mg and administer has two 10mg capsules and one 4mg capsule given orally, once daily taken with or without food. The Lenvatinib tablet should continue until disease progression or until unacceptable toxicity occurs. Take Lenvatinib tablet at the same time. Patients with severe renal or hepatic impairment the dose is 14mg administer once daily orally.

Over dosage

Lenvatinib is not expected to be dialyzable because of high plasma protein binding and if the dose receiving of lenvatinib 4mg 120mg orally then causes death due to multiorgan dysfunction occurred in the patients.

Common side effects

Tiredness, Peeling of skin on palms and sole of the feet, Constipation, Loss of appetite, Weight loss, Joint and muscle pain, Insomnia

Serious side effects

Shortness of breath, Chest pain, Pain in arm, back, neck or jaw, Seizures, Black, tarry or bloody stools, Heavy menstrual bleeding, Coughing up blood, Yellowing of the skin or eyes

Blood pressure may rises while treatment with lenvatinib 4mg . Your doctor will preferably check your blood pressure during your treatment.

Allergic reaction
Inform the doctor if you are allergic to lenvatinib 4mg , any other regimens, or any of the ingredients in lenvatinib 4mg capsules. other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may to change the doses of your drugs or guide carefully for adverse reaction.

OT interval Prolongation
Inform doctor if you have or had seizures, hypertension, a stroke, a heart attack, , especially those due to blood clots, a fistula, a tear in the wall of your GIT, QT interval prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death), low levels of Ca,K or Mg in your blood, bleeding problems, or cardiac, renal, or hepatic disease.

Embryofetal Toxicity
Take into the knowledge that lenvatinib 4mg may reduce the fertility in men and women. It not means that you or your partner cannot become pregnant. Inform doctor before if you are pregnant or plan to become pregnant. After becoming pregnant, you should use birth control while treatment with lenvatinib 4mg and for at least 2 weeks after your treatment, become pregnant duringLenvatinib therapy, call your doctor immediately. lenvatinib 4mg may harm the fetus. Inform the doctor if you are breastfeeding or plan to breastfeed. Avoid breastfeed during lenvatinib 4mg treatment.


  • lenvatinib 4mg concomitant use with Carboplatin, paclitaxel has no specific pharmacokinetics impact
  • Combination with CYP3A, Pglycoprotein (P-gp) inhibitors and inducers has no dose adjustment for lenvatinib 4mg

When administrated to pregnant, lenvatinib 4mg drugs can cause harm to the fetal. There are no available human data related to drug associated risk. Advice pregnant women specific risk to fetus.

It’s not known that drug is present in human milk. Excretion in human milk is unknown. Because of the serious side effects in infants from the drug, advice to avoid breast feeding during treatment with lenvatinib 4mg .

Store at 25°C lenvatinib 4mg is supplied in cartoons cards Keep out of the children hands Discard the after-expiry date

If patients fail to administer the dose of drug and should be take within the time and cannot be taken within 12 hours, otherwise the missed dose should be skipped and follow the next dosing schedule. Please consult with the doctor


Quick Contact

Prescription upload


Blueberrypharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Blueberrypharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Blueberrypharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Blueberrypharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Blueberrypharma.com

At Blueberrypharma.com , a Caregiver can order prescription medicines on your behalf.